Intelligence Platform

Patents

Browse 124 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 6794373

Contraceptive methods using benzimidazolones

Ligand Pharmaceuticals Incorporated · Granted Tue Sep 21 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6759408

Combination regimens using progesterone receptor modulators

Ligand Pharmaceuticals Incorporated · Granted Tue Jul 06 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6713478

Cyclocarbamate derivatives as progesterone receptor modulators

Ligand Pharmaceuticals Incorporated · Granted Tue Mar 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6696459

Steroid receptor modulator compounds and methods

Ligand Pharmaceuticals Incorporated · Granted Tue Feb 24 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6693103

1,2,3,4-tetrahydro-2-thioxo-quinolinyl and 1,2,3,4-tetrahydro-2-oxo-quinolinyl derivatives

Ligand Pharmaceuticals Incorporated · Granted Tue Feb 17 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6670387

Thrombopoietin mimetics

Ligand Pharmaceuticals Incorporated · Granted Tue Dec 30 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6667313

8-substituted-6-triflouromethyl-9-pyrido [3,2-G] quinoline compounds as androgen receptor

Ligand Pharmaceuticals Incorporated · Granted Tue Dec 23 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6610696

Modulators of peroxisome proliferator activated receptors

Ligand Pharmaceuticals Incorporated · Granted Tue Aug 26 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6608068

Indoline derivatives

Ligand Pharmaceuticals Incorporated · Granted Tue Aug 19 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6593493

RXR modulators with improved pharmacologic profile

Ligand Pharmaceuticals Incorporated · Granted Tue Jul 15 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6583145

Thio-oxindole derivatives

Ligand Pharmaceuticals Incorporated · Granted Tue Jun 24 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6576676

Means for the modulation of processes mediated by retinold receptors and compounds useful

Ligand Pharmaceuticals Incorporated · Granted Tue Jun 10 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6566372

Bicyclic androgen and progesterone receptor modulator compounds and methods

Ligand Pharmaceuticals Incorporated · Granted Tue May 20 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6566358

Cyclocarbamate derivatives as progesterone receptor modulators

Ligand Pharmaceuticals Incorporated · Granted Tue May 20 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6545049

Dimer-selective RXR modulators and methods for their use

Ligand Pharmaceuticals Incorporated · Granted Tue Apr 08 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6544970

Cyclic regimens utilizing indoline derivatives

Ligand Pharmaceuticals Incorporated · Granted Tue Apr 08 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6521657

Thio-oxindole derivatives

Ligand Pharmaceuticals Incorporated · Granted Tue Feb 18 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6521633

Treating NIDDM with RXR agonists

Ligand Pharmaceuticals Incorporated · Granted Tue Feb 18 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6509334

Cyclocarbamate derivatives as progesterone receptor modulators

Ligand Pharmaceuticals Incorporated · Granted Tue Jan 21 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6506766

Glucocortiocoid-selective antinflammatory agents

Ligand Pharmaceuticals Incorporated · Granted Tue Jan 14 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6503939

Combination regimens using 3,3-substituted indoline derivatives

Ligand Pharmaceuticals Incorporated · Granted Tue Jan 07 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6498154

Cyclic regimens using quinazolinone and benzoxazine derivatives

Ligand Pharmaceuticals Incorporated · Granted Tue Dec 24 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6462032

Cyclic regimens utilizing indoline derivatives

Ligand Pharmaceuticals Incorporated · Granted Tue Oct 08 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6462038

Androgen receptor modulator compounds and methods

Ligand Pharmaceuticals Incorporated · Granted Tue Oct 08 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired